• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国国家癌症研究所的出版物归属难题:重新构建创新模式,以激励为倡导者代表提供公平的途径。

NCI's publication affiliation conundrum: Reframing innovation to incentivize an equitable path for advocate representation.

作者信息

Samson Susan, Northey Jason J, Acerbi Irene, Goga Andrei, Flink Carl L, Weaver Valerie M, LaBarge Mark A

机构信息

Breast Oncology Program, Breast Science Advocacy Core (BSAC), University of California, San Francisco, 2340 Sutter Street, San Francisco, CA 94115; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94115, United States; Physical Sciences and Oncology Network Program, University of California, San Francisco, CA 94115, United States.

Department of Surgery and Center for Bioengineering and Tissue Regeneration, University of California, San Francisco, CA 94143, United States.

出版信息

Transl Oncol. 2022 Feb;16:101325. doi: 10.1016/j.tranon.2021.101325. Epub 2021 Dec 30.

DOI:10.1016/j.tranon.2021.101325
PMID:34974281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8728534/
Abstract

Advocacy engagement has been at the forefront of National Cancer Institute (NCI) efforts to advance scientific discoveries and transform medical interventions. Nonetheless, the journey for advocates has been uneven. Case in Point: NCI publication affiliation rules of engagement pose unique equity challenges while raising questions about structural representation in biomedical research. Abiding by the core rationale that publication affiliation should be tailored to employment status, the NCI has systematically denied research advocate volunteers the opportunity to specifically list NCI as an institutional affiliation on academic publications. Unpacking advocate NCI publication affiliation restrictions and its links with advocacy heritage preservation and convergent science goals poses unique diversity, equity, and inclusion challenges and opportunities. Improving the quality of structural representation in biomedical research requires new theories of action and flexible planning to advance, promote and build capacity for strategic advocacy inclusion and equity within publication affiliation initiatives. Here we highlight several opportunities for how leadership might formulate a radically different vision for NCI's approach. This perspective interrogates the best way forward for ensuring that biomedical employee and volunteer advocate workforce publication affiliation intersections are characterized by increased creativity and representation parity. Imbuing the scientist and clinical researcher archetype with social dimensions, we join NCI critical thinkers in urging employees, funded academics, and volunteer citizen scientists to collectively assume the role as paladins of science and integrity who view the triumphs of making a difference in science alongside the social responsibility of promoting transdisciplinary professionalism and the democratization of science.

摘要

倡导参与一直是美国国立癌症研究所(NCI)推动科学发现和变革医学干预措施努力的前沿。尽管如此,倡导者的历程并不平坦。举个例子:NCI关于出版物附属关系的参与规则带来了独特的公平挑战,同时也引发了关于生物医学研究中结构代表性的问题。遵循出版物附属关系应根据就业状况进行调整的核心原则,NCI系统性地剥夺了研究倡导者志愿者在学术出版物上特别将NCI列为机构附属关系的机会。剖析倡导者在NCI出版物附属关系方面的限制及其与倡导遗产保护和融合科学目标的联系,带来了独特的多样性、公平性和包容性挑战与机遇。提高生物医学研究中结构代表性的质量需要新的行动理论和灵活的规划,以推进、促进并建设出版物附属关系倡议中战略倡导包容性和公平性的能力。在此,我们强调领导层可能如何为NCI的方法制定截然不同愿景的几个机会。这一观点探讨了确保生物医学员工和志愿者倡导者群体在出版物附属关系中的交集具有更高创造力和代表性平等的最佳前进方向。我们赋予科学家和临床研究人员原型以社会维度,与NCI的批判性思考者一道,敦促员工、获得资助的学者和志愿者公民科学家共同承担起科学与诚信圣骑士的角色,他们将见证在科学中有所作为的胜利,同时肩负起促进跨学科专业性和科学民主化的社会责任。

相似文献

1
NCI's publication affiliation conundrum: Reframing innovation to incentivize an equitable path for advocate representation.美国国家癌症研究所的出版物归属难题:重新构建创新模式,以激励为倡导者代表提供公平的途径。
Transl Oncol. 2022 Feb;16:101325. doi: 10.1016/j.tranon.2021.101325. Epub 2021 Dec 30.
2
Improving Patient Advocacy in NCI Scientific Steering Committees and Task Forces.提高 NCI 科学指导委员会和工作组中的患者倡导力度。
J Natl Cancer Inst. 2022 Aug 8;114(8):1059-1064. doi: 10.1093/jnci/djac089.
3
Advocacy for health equity: a synthesis review.健康公平倡导:一项综合综述。
Milbank Q. 2015 Jun;93(2):392-437. doi: 10.1111/1468-0009.12112.
4
Advancing inclusive science and systemic change: the convergence of national aims and institutional goals in implementing and assessing biomedical science training.推进包容性科学与系统性变革:国家目标与机构目标在生物医学科学培训实施与评估中的融合。
BMC Proc. 2017 Dec 4;11(Suppl 12):17. doi: 10.1186/s12919-017-0086-5. eCollection 2017.
5
Australia in 2030: what is our path to health for all?2030 年的澳大利亚:全民健康之路在何方?
Med J Aust. 2021 May;214 Suppl 8:S5-S40. doi: 10.5694/mja2.51020.
6
The Prevalence of Dissemination and Implementation Research and Training Grants at National Cancer Institute-Designated Cancer Centers.国家癌症研究所指定癌症中心的传播和实施研究及培训补助金的流行情况。
JNCI Cancer Spectr. 2021 Dec 15;6(1). doi: 10.1093/jncics/pkab092. eCollection 2022 Feb.
7
Supporting cancer survivors' participation in peer review: perspectives from NCI's CARRA program.支持癌症幸存者参与同行评审:NCI 的 CARRA 计划的观点。
J Cancer Surviv. 2014 Mar;8(1):114-20. doi: 10.1007/s11764-013-0318-2. Epub 2013 Nov 9.
8
Constituent-driven health policy informed by policy advocacy literature.由政策倡导文献提供信息的选民驱动型卫生政策。
Transl Behav Med. 2023 May 13;13(5):338-342. doi: 10.1093/tbm/ibac116.
9
Culture of Care: Organizational Responsibilities关怀文化:组织职责
10
Inter-Institutional Partnerships to Develop Veterinarian-Investigators through the NIH Comparative Biomedical Scientist Training Program Benefit One Health Goals.通过美国国立卫生研究院比较生物医学科学家培训计划建立机构间伙伴关系以培养兽医研究人员,有益于“同一健康”目标。
J Vet Med Educ. 2020 Oct;47(5):619-631. doi: 10.3138/jvme.2019-0091.

本文引用的文献

1
Promoting Equity for Women in Medicine - Seizing a Disruptive Opportunity.促进医学领域女性的公平——抓住一个颠覆性机遇。
N Engl J Med. 2021 Jun 17;384(24):2265-2267. doi: 10.1056/NEJMp2104228. Epub 2021 Jun 12.
2
Affirming NIH's commitment to addressing structural racism in the biomedical research enterprise.美国国立卫生研究院承诺致力于解决生物医学研究领域的结构性种族主义问题。
Cell. 2021 Jun 10;184(12):3075-3079. doi: 10.1016/j.cell.2021.05.014.
3
Expedited Development Programs at the Food and Drug Administration: Insights and Opportunities.美国食品药品监督管理局的加速发展计划:见解与机遇。
Ther Innov Regul Sci. 2021 May;55(3):619-621. doi: 10.1007/s43441-021-00258-z. Epub 2021 Feb 2.
4
Education and Outreach in Physical Sciences in Oncology.肿瘤学中物理科学的教育与拓展。
Trends Cancer. 2021 Jan;7(1):3-9. doi: 10.1016/j.trecan.2020.10.007. Epub 2020 Nov 7.
5
Systemic racism in higher education.高等教育中的系统性种族主义。
Science. 2020 Sep 18;369(6510):1440-1441. doi: 10.1126/science.abd7140.
6
Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and Development.衡量患者参与和以患者为中心在临床研究与开发中的影响。
Ther Innov Regul Sci. 2020 Jan;54(1):103-116. doi: 10.1007/s43441-019-00034-0. Epub 2020 Jan 6.
7
Publications as predictors of racial and ethnic differences in NIH research awards.出版物作为 NIH 研究奖项中种族和民族差异的预测指标。
PLoS One. 2018 Nov 14;13(11):e0205929. doi: 10.1371/journal.pone.0205929. eCollection 2018.
8
The continuing evolution of publishing in the biological sciences.生物科学领域出版业的持续发展。
Biol Open. 2018 Aug 28;7(8):bio037325. doi: 10.1242/bio.037325.
9
Promoting Scientist-Advocate Collaborations in Cancer Research: Why and How.促进癌症研究中的科学家-倡导者合作:为什么以及如何。
Cancer Res. 2018 Oct 15;78(20):5723-5728. doi: 10.1158/0008-5472.CAN-18-1600. Epub 2018 Aug 17.
10
What do stakeholders expect from patient engagement: Are these expectations being met?利益相关者对患者参与有哪些期望:这些期望得到满足了吗?
Health Expect. 2018 Dec;21(6):1035-1045. doi: 10.1111/hex.12797. Epub 2018 Jun 1.